Managing CRE, CDE and Best Effort Obligations in Life Science Transactions

13 Oct 2026
Strategy 26 Exchange: Interactive Roundtable Discussions
Deal obligations, such as Commercially Reasonable Effort (CRE), Commercially Diligent Effort (CDE) and “best effort” clauses, play a central role in allocating developmental and commercialisation risk in life science transactions. This discussion will examine how these obligations are defined, managed and enforced, and how teams can mitigate risk exposure under these obligations across collaboration and licensing agreements.